Head-to-head comparison of three breast cancer drugs reveals important differences

[News]

Every year, more than 250,000 women in the U.S. are diagnosed with breast cancer. When detected early, patients with the most common form--which tests positive for hormone receptors (HR+) and negative for the HER2 receptor--usually respond well to treatment.

More... (https://www.news-medical.net/news/20190823/Head-to-head-comparison-of-three-breast-cancer-drugs-reveals-important-differences.aspx)